amphetamine has been researched along with Atrophy in 8 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 7.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
| "The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 3.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
| "One hundred ten patients with alcohol dependence and 56 psychiatric patients with either senile dementia, amphetamine psychosis, epilepsy or chronic schizophrenia were investigated with a CT scan of the brain." | 3.68 | Computerized tomographic study on the brain of patients with alcohol dependence. ( Kato, A; Nakajima, T; Nakamura, M; Tsuji, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muhammad, A | 1 |
| Kolb, B | 1 |
| Bazzett, TJ | 1 |
| Becker, JB | 1 |
| Kaatz, KW | 1 |
| Albin, RL | 1 |
| Rosenblad, C | 1 |
| Kirik, D | 1 |
| Devaux, B | 1 |
| Moffat, B | 1 |
| Phillips, HS | 1 |
| Björklund, A | 1 |
| Freire-Garabal, M | 1 |
| Núñez, MJ | 1 |
| Balboa, J | 1 |
| Rodríguez-Cobo, A | 1 |
| López-Paz, JM | 1 |
| Rey-Méndez, M | 1 |
| Suárez-Quintanilla, JA | 1 |
| Millán, JC | 1 |
| Mayán, JM | 1 |
| Puschban, Z | 1 |
| Scherfler, C | 1 |
| Granata, R | 1 |
| Laboyrie, P | 1 |
| Quinn, NP | 1 |
| Jenner, P | 1 |
| Poewe, W | 1 |
| Wenning, GK | 1 |
| Roghani, M | 1 |
| Behzadi, G | 1 |
| Kato, A | 1 |
| Tsuji, M | 1 |
| Nakamura, M | 1 |
| Nakajima, T | 1 |
| Stern, WC | 1 |
| Hartmann, EL | 1 |
8 other studies available for amphetamine and Atrophy
| Article | Year |
|---|---|
Maternal separation altered behavior and neuronal spine density without influencing amphetamine sensitization.
Topics: Amphetamine; Animals; Atrophy; Brain; Dendritic Spines; Disease Models, Animal; Female; Frontal Lobe | 2011 |
Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Topics: Amphetamine; Animals; Atrophy; Corpus Striatum; Dialysis; Dose-Response Relationship, Drug; Electron | 1993 |
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Topics: Amphetamine; Animals; Antibodies; Apomorphine; Atrophy; Body Weight; Cerebral Ventricles; Corpus Str | 1999 |
Effects of amphetamine on development of oral candidiasis in rats.
Topics: Amphetamine; Animals; Atrophy; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Male; M | 1999 |
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Autoradiography; Behavior, Animal; Brain Tissue Transpla | 2000 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Anima | 2001 |
Computerized tomographic study on the brain of patients with alcohol dependence.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Withdrawal Delirium; Alcoholism; Amphetamine; Atrophy; Brain | 1991 |
Reduced amphetamine lethality following chronic stress.
Topics: Adrenal Glands; Adrenocortical Hyperfunction; Amphetamine; Animals; Atrophy; Hypertrophy; Immersion; | 1972 |